Freedom Leaf Inc. Announces National Distribution Agreement

With this type of sales interest, Freedom Leaf is projecting revenue of $2,000,000 for the Hempology product line for 2018

LAS VEGAS, NV, Feb. 28, 2018 -- Freedom Leaf, Inc. (OTCQB: FRLF), a group of diversified, international, vertically-integrated Cannabis/Hemp business and media companies, today announced that it is developing multiple strategic partnerships through their wholly owned extraction division Leafceuticals Inc., and through their exclusively owned CBD product line Hempology.

Freedom Leaf has signed a National Distribution Agreement with Quality Products Distribution Inc., the distributor of the Accuvape vaporizer line. Hilary Dulany, CEO of Quality Products Distribution Inc., signed the agreement alongside Clifford Perry, CEO of Freedom Leaf, for distribution rights of the Hempology CBD line to their large network of retail stores across the country. With this type of sales interest, Freedom Leaf is projecting revenue of $2,000,000 for the Hempology product line for 2018.

Chris Thompson, Freedom Leaf’s Director of Digital Marketing, who helped close the Distribution Agreement, explained, “Signing a national distributor like Quality Products Distribution Inc. was one of our major goals with the Hempology line. Now that Hilary’s experienced sales team will be presenting our CBD products to dispensaries and retail stores, we expect a steady growth of wholesale orders in the coming weeks.”

In addition to the new Distribution Agreement, the Hempology CBD product line will also now be available in brick and mortar retail stores in over 10 states due to a large influx of wholesale orders from the recent Champs Trade Show and Tobacco Plus Expo in Las Vegas.

Freedom Leaf CEO and Co-Founder, Clifford Perry, stated, “We are creating a strong foundation for our international company through multiple positive relationships with key industry players. These strategic partnerships will continue to bring Freedom Leaf to the forefront of the emerging Cannabis/Hemp industry.”

Freedom Leaf’s extraction division, Leafceuticals Inc., has completed a successful extraction of nearly 600 pounds of industrial hemp from Pahrump, NV and will be utilizing the high-quality full-spectrum CBD oil directly in the Hempology CBD product line.

Through the strategic partnership with manufacturer NutraFuels (OTCMKTS: NTFU), Freedom Leaf will be able to capitalize on the full retail value of the first industrial hemp CBD extraction by manufacturing the Hempology line with their own extracted CBD. This move will cut production costs of the Hempology CBD line and moves Freedom Leaf towards being a fully vertically-integrated company.

About Freedom Leaf®

Freedom Leaf, Inc., The Marijuana Legalization Company®, is a fully-reporting and audited, publicly-traded company trading under the symbol (OTCQB: FRLF), a group of diversified, international, vertically-integrated Cannabis/Hemp/CBD businesses and media companies

Freedom Leaf, Inc. is a leading, go-to resource in the cannabis, medical and recreational marijuana, CBD and industrial hemp industries.  It is involved in mergers and acquisitions in these industries, including acceleration and spin offs of new companies involved in those industries.

Freedom Leaf Inc.'s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. The company produces a portfolio of news, print and digital multi-media verticals, websites, and web advertising, for the ever changing emerging cannabis, medical marijuana and industrial hemp industry.  The Company also controls LaMarihuana.com, the world’s leading Spanish publication focused on these industries.

Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana or related products.

All of our European activities are in full compliance with relevant EU laws.

Investor relations information can be found on the FreedomLeafInc.com company website.

Safe Harbor Statement

Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by phrases such as Freedom Leaf, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Factors that could cause or contribute to differences include the uncertainty regarding viability and market acceptance of the Company's products and services, changes in relationships with third parties, and other factors described in the Company's most recent periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K dated June 30, 2016 and quarterly reports on Form 10-Q.

Contact:

Raymond Medeiros

PR and Business Development Director

Phone: 415-601-1974

[email protected]

Freedom Leaf, Inc.